3D Systems is selling medical procedure simulation business, Simbionix, to Surgical Science Sweden AB for $305 million. Simbionix's 2020 revenue was $40.8 million. The sale of the division will allow 3D Systems to focus on additive manufacturing. The transaction is scheduled to close in August 2021.